Discontinuation report RUZURGI
| Report ID | 156611 |
| Drug Identification Number | 02503034 |
| Brand name | RUZURGI |
| Common or Proper name | Amifapridine |
| Company Name | MEDUNIK CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 tablets |
| ATC code | N07XX |
| ATC description | |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2022-03-12 |
| Actual discontinuation date | 2022-03-12 |
| Remaining supply date | 2022-03-12 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | NOC retrival due to legal cause |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 950 MICHÈLE-BOHEC BLVD. BLAINVILLE, QUEBEC CANADA J7C 5E2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-03-14 | English | Compare |
| v2 | 2022-03-14 | English | Compare |
| v3 | 2022-03-14 | English | Compare |
| v4 | 2022-03-14 | English | Compare |
| v5 | 2022-03-14 | French | Compare |
| v6 | 2023-01-27 | English | Compare |
| v7 | 2023-01-27 | French | Compare |
Showing 1 to 7 of 7